Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Placebo-controlled, Double-blind, Randomized Clinical Trial in Parallel Groups to Evaluate the Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

NCT04250311 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT04250311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04250311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Placebo-controlled, Double-blind, Randomized Clinical Trial in Parallel Groups to Evaluate the Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Suspended
Start date
December 12, 2019
Completion date
December 31, 2024
Enrollment
314 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

influenza